
Zelaino Pharmaceuticals Private Limited
About Zelaino Pharmaceuticals Private Limited
Data last updated:
Zelaino Pharmaceuticals Private Limited is a private limited company based in Solapur, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 22 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2019PTC187947. Its GSTIN is 27AABCZ4587H1ZU (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tulsa Subhash Bidri and Roopa Vivek Bidri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/30 New Paccha Peth, Solapur, Maharashtra, India – 413006.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.43 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹9.52 Lakh (net margin 6.7%) and EBITDA of ₹15.77 Lakh (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years.
Company details
Contact details
Zelaino Pharmaceuticals Private Limited's registered office is in Solapur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address15/30 New Paccha Peth, Solapur, Maharashtra, India – 413006
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Zelaino Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zelaino Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Zelaino Pharmaceuticals Private Limited, buy the company report.
Financials of Zelaino Pharmaceuticals Private Limited
FY 2025 filings availableZelaino Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 55% over three years, including 40% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.52 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zelaino Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zelaino Pharmaceuticals Private Limited
Zelaino Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tulsa Subhash Bidri | Director | 22 Nov 2019 | 6 Years 11 Months | Current |
| Roopa Vivek Bidri | Director | 22 Nov 2019 | 6 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Zelaino Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zelaino Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zelaino Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ4587H1ZU | Maharashtra | Active | 30 Jan 2020 |
To see the full GST registrations and return filing status of Zelaino Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zelaino Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Roopa Vivek Bidri was appointed as Director on 22 Nov 2019.
Frequently asked questions
Zelaino Pharmaceuticals is an active private limited company based in Solapur, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 22 November 2019 (7+ years old) and is registered under CIN U74999PN2019PTC187947.
Zelaino Pharmaceuticals has 2 current directors:
- Tulsa Subhash Bidri - Director
- Roopa Vivek Bidri - Director
The latest financial statements of Zelaino Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Zelaino Pharmaceuticals is 27AABCZ4587H1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zelaino Pharmaceuticals is U74999PN2019PTC187947. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zelaino Pharmaceuticals was incorporated on 22 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Roopa Vivek Bidri was appointed as Director on 22 Nov 2019. Tulsa Subhash Bidri was appointed as Director on 22 Nov 2019.
The registered office of Zelaino Pharmaceuticals is at 1530 New Paccha Peth, Solapur, Maharashtra, India – 413006.
Zelaino Pharmaceuticals operates in the business services industry, in the other services segment.
Zelaino Pharmaceuticals can be reached at its registered office: 1530 New Paccha Peth, Solapur, Maharashtra, India – 413006.

